Literature DB >> 38072

Pharmacokinetics and analgesic effect of pethidine (meperidine) and its metabolites in the rat.

B E Dahlström, L K Paalzow, C Lindberg, C Bogentoft.   

Abstract

The pharmacokinetics of pethidine (meperidine) and norpethidine (normeperidine) have been investigated after iv administration of pethidine in the rat. The plasma concentration-time curve for pethidine could be described by a triexponential function. The calculated half-lives were 6.0, 18.5, and 64.5 min. Norpethidine, metabolically formed from pethidine, reached maximum plasma concentrations after 30 min and declined biexponentially with half-lives of 66.8 and 301 min. The time course of analgesia after iv administration of pethidine, norpethidine, and p-hydroxypethidine has also been evaluated. When the pharmacokinetic data were compared with the time course of analgesia, the plasma levels of pethidine could be correlated with the analgesic effect after the first rapid distribution phase. The pharmacokinetic constants for pethidine and norpethidine were used to stimulate the plasma levels of these compounds after multiple doses of pethidine. Accumulation of norpethidine was demonstrated to occur, which may be of importance when toxic and analgesic effects of pethidine are evaluated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 38072

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  11 in total

Review 1.  Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.

Authors:  D E Drayer
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of pethidine: 1982.

Authors:  D J Edwards; C K Svensson; J P Visco; D Lalka
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

3.  Effects of narcotic analgesics, especially pethidine and norpethidine, on renal pelvic smooth muscle in patients with hydronephrosis.

Authors:  A C Kinn; L O Boréus; A Nergårdh
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models.

Authors:  Sven Björkman
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-08       Impact factor: 2.745

5.  Comparative disposition of pethidine and norpethidine in old and young patients.

Authors:  L Holmberg; I Odar-Cederlöf; L O Boréus; L Heyner; M Ehrnebo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  CSF and plasma pharmacokinetics of pethidine and norpethidine in man after epidural and intrathecal administration of pethidine.

Authors:  G Nordberg; V Hansdottir; U Bondesson; L O Boréus; T Mellstrand; T Hedner
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.

Authors:  C A Paronis; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

8.  Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients.

Authors:  I Odar-Cederlöf; L O Boréus; U Bondesson; L Holmberg; L Heyner
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model.

Authors:  J L Gabrielsson; P Johansson; U Bondesson; M Karlsson; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1986-08

10.  Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses.

Authors:  Briana D Hamamoto-Hardman; Eugene P Steffey; Daniel S McKemie; Philip H Kass; Heather K Knych
Journal:  BMC Vet Res       Date:  2020-10-01       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.